196 Chapter 7 28. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia. 2011;7:263-9. 29. Slot RE, Verfaillie SC, Overbeek JM, Timmers T, Wesselman LM, Teunissen CE, et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimer’s research & therapy. 2018;10:1-13. 30. Tijms BM, Willemse EA, Zwan MD, Mulder SD, Visser PJ, van Berckel BN, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-β 1–42 analysis results. Clinical Chemistry. 2018;64:576-85. 31. Golla SS, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, et al. Quantification of tau load using [18F] AV1451 PET. Molecular imaging and biology. 2017;19:963-71. 32. Tuncel H, Visser D, Yaqub M, Timmers T, Wolters EE, Ossenkoppele R, et al. Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F] Flortaucipir Studies. Molecular imaging and biology. 2021;23:604-13. 33. Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human brain mapping. 2003;19:224-47. 34. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbøl S, Frøkjær VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24:969-79. 35. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-87. 36. Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, et al. Parametric methods for [18F] flortaucipir PET. Journal of Cerebral Blood Flow & Metabolism. 2020;40:365-73. 37. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61:1402-18. 38. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968-80. 39. Lindroth H, Nair VA, Stanfield C, Casey C, Mohanty R, Wayer D, et al. Examining the identification of age-related atrophy between T1 and T1+ T2-FLAIR cortical thickness measurements. Scientific reports. 2019;9:1-11. 40. Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, et al. Longitudinal tau accumulation and atrophy in aging and alzheimer disease. Annals of Neurology. 2019;85:229-40. 41. van Berckel BN, Ossenkoppele R, Tolboom N, Yaqub M, Foster-Dingley JC, Windhorst AD, et al. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations. Journal of Nuclear Medicine. 2013;54:1570-6. 42. Visser D, Tuncel H, Ossenkoppele R, Yaqub MM, Wolters EE, Timmers T, et al. Longitudinal tau PET using 18F-flortaucipir: the Effect of relative Cerebral Blood Flow on (semi) quantitative parameters. Journal of Nuclear Medicine. 2022.
RkJQdWJsaXNoZXIy MjY0ODMw